Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
Kooner Fleet Management Solutions said its new FleetIQ technology platform can help its fleet customers streamline service ...
XRP holders can now stake tokens through XRP Tundra, a new DeFi platform built on Ripple's EVM sidechain and fully audited ...
Elon Musk’s Grokipedia has launched. Here’s how it differs from Wikipedia - the encyclopedia it’s expected to rival.
FREDERICK, MD, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- VaLogic Bio has acquired Air Systems Technologies (AST), expanding the services available to life ...
SOUTH SAN FRANCISCO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation ...
The positive preliminary SENTI-202 clinical data was presented on April 27 in a Clinical Trials Oral Minisymposium at the American Association for Cancer Research (AACR) Annual Meeting 2025 in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback